Some molecular genetic features including IDH1/2 mutation, MGMT promoter methylation, co-deletion of 1p/19q, TERT loss, and ATRX mutation have been reported to be associated with favorable prognosis in gliomas. This evidence concerns the gene MGMT and glioma.